Organism name | Smilax china |
---|---|
Genus | Smilax |
Family | Smilacaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Smilax china |
---|---|
Linked NCBI taxonomy ID | 49657 |
Linked level | species |
Family in NCBI taxonomy | Smilacaceae |
---|---|
ID | 4703 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Liliopsida |
---|---|
ID | 4447 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00003575
![]() |
Dioscin
|
CHEMBL507001
CHEMBL2036081 CHEMBL2036082 |
C019357
|
0 / 2 | No. 17 | No. 11 |
![]() |
|
C00030764
![]() |
Smilax saponin B
/ Methylprotodioscin / Methyl protodioscin / (-)-Methylprotodioscin |
CHEMBL453625
CHEMBL1993106 CHEMBL2004298 |
No. 21 | No. 11 |
![]() |
|||
C00003585
![]() |
Protodioscin
/ 3beta,22alpha,26-Trihydroxyfurost-5-ene-3-O-beta-chacotrioside-26-O-beta-D-glucopyranoside |
CHEMBL1163175
CHEMBL1981285 CHEMBL1995734 |
No. 21 | No. 11 |
![]() |
|||
C00031101
![]() |
Pseudoprotodioscin
/ (-)-Pseudoprotodioscin |
No. 21 | No. 11 |
![]() |
||||
C00003672
![]() |
Sitosterol
/ beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 |
![]() |
||
C00003576
![]() |
Diosgenin
|
CHEMBL412437
CHEMBL1551855 CHEMBL1553328 |
D004144
|
6 / 10 / 7 | 15 / 2 | No. 171 | No. 11 |
![]() |
C00043008
![]() |
Smilaside F
/ (+)-Smilaside F |
CHEMBL500983
|
No. 334 |
![]() |
||||
C00043007
![]() |
Smilaside E
/ (+)-Smilaside E |
CHEMBL507530
|
No. 334 |
![]() |
||||
C00043006
![]() |
Smilaside D
/ (+)-Smilaside D |
CHEMBL490680
|
No. 334 |
![]() |
||||
C00043005
![]() |
Smilaside C
/ (+)-Smilaside C |
CHEMBL502580
|
No. 334 |
![]() |
||||
C00043004
![]() |
Smilaside B
/ (+)-Smilaside B |
CHEMBL475478
|
No. 418 |
![]() |
||||
C00033906
![]() |
Helonioside A
|
CHEMBL2151691
|
No. 418 |
![]() |
||||
C00043003
![]() |
Smilaside A
|
CHEMBL446732
|
No. 418 |
![]() |
||||
C00019308
![]() |
Doursterol
/ Daucosterin / 3-O-beta-D-Glucopyranosyl sitosterol / beta-Sitosterol 3-O-beta-D-glucopyranoside |
CHEMBL197711
CHEMBL506678 CHEMBL2304043 |
C011015
|
5 / 4 / 2 | 0 / 3 | No. 520 |
![]() |
|
C00030221
![]() |
Ethyl caffeate
/ Ethyl 3,4-dihydroxy cinnamate |
CHEMBL17347
|
C032773
|
No. 876 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P00734 | Prothrombin | S1A | C00003672 C00019308 | 4 / 2 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00003576 C00003672 | 0 / 1 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003672 C00019308 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 C00019308 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00003672 C00019308 | 0 / 0 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00003672 C00019308 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00003672 | 1 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00003672 | 1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003672 | 0 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003672 | 2 / 0 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00003576 | 1 / 2 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00003672 | 3 / 2 |
P14679 | Tyrosinase | Oxidoreductase | C00003672 | 4 / 2 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00003672 | 0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00003576 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00003672 | 1 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003672 | 1 / 1 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00003576 | 3 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00003576 | 5 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00003576 | 4 / 3 |
P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 | 1 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00003672 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00003576
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00003576
|
597 | BCL2A1, ACC-1, ACC-2, BCL2L5, BFL1, GRS, HBPA1 | BCL2-related protein A1 |
C00003576
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00003576
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00003576
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00003576
|
8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00003576
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00003576
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00003576
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00003576
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00003576
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00003576
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00003576
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00003576
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00003576
|
OMIM | preferred title | UniProt |
---|---|---|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#218030 | Apparent mineralocorticoid excess; ame |
P80365
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601367 | Stroke, ischemic |
P00734
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
KEGG | name | UniProt |
---|---|---|
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00016 | Oral cancer |
P40763
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D002493 | Central Nervous System Diseases |
C00019308
|
D003072 | Cognition Disorders |
C00019308
|
D013118 | Spinal Cord Diseases |
C00019308
|
D056486 | Drug-Induced Liver Injury |
C00003575
|
D009336 | Necrosis |
C00003575
|
D002779 | Cholestasis |
C00003576
|
D006949 | Hyperlipidemias |
C00003576
|